搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella typhimurium Ribosome-binding factor A (rbfA) CSB-YP838462SXB
CSB-EP838462SXB
CSB-BP838462SXB
CSB-MP838462SXB
CSB-EP838462SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Serine/threonine transporter sstT (sstT), partial CSB-YP838463SXB
CSB-EP838463SXB
CSB-BP838463SXB
CSB-MP838463SXB
CSB-EP838463SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium 2,5-diketo-D-gluconic acid reductase A (dkgA) CSB-YP838464SXB
CSB-EP838464SXB
CSB-BP838464SXB
CSB-MP838464SXB
CSB-EP838464SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Putative Holliday junction resolvase (yqgF) CSB-YP838465SXB
CSB-EP838465SXB
CSB-BP838465SXB
CSB-MP838465SXB
CSB-EP838465SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Isopentenyl-diphosphate Delta-isomerase (idi) CSB-YP838466SXB
CSB-EP838466SXB
CSB-BP838466SXB
CSB-MP838466SXB
CSB-EP838466SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Protease 3 (ptrA), partial CSB-YP838467SXB
CSB-EP838467SXB
CSB-BP838467SXB
CSB-MP838467SXB
CSB-EP838467SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium 23S rRNA (uracil (1939)-C (5))-methyltransferase RlmD (rlmD) CSB-YP838468SXB
CSB-EP838468SXB
CSB-BP838468SXB
CSB-MP838468SXB
CSB-EP838468SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Anaerobic nitric oxide reductase flavorubredoxin (norV) CSB-YP838469SXB
CSB-EP838469SXB
CSB-BP838469SXB
CSB-MP838469SXB
CSB-EP838469SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Cysteine/O-acetylserine efflux protein (eamB), partial CSB-YP838470SXB1
CSB-EP838470SXB1
CSB-BP838470SXB1
CSB-MP838470SXB1
CSB-EP838470SXB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Chaperone protein hscA (hscA), partial CSB-YP838471SXB
CSB-EP838471SXB
CSB-BP838471SXB
CSB-MP838471SXB
CSB-EP838471SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium UPF0214 protein yfeW (yfeW) CSB-YP838472SXB
CSB-EP838472SXB
CSB-BP838472SXB
CSB-MP838472SXB
CSB-EP838472SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium 3-ketoacyl-CoA thiolase (fadI) CSB-YP838473SXB
CSB-EP838473SXB
CSB-BP838473SXB
CSB-MP838473SXB
CSB-EP838473SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium UPF0208 membrane protein YfbV (yfbV), partial CSB-YP838474SXB1
CSB-EP838474SXB1
CSB-BP838474SXB1
CSB-MP838474SXB1
CSB-EP838474SXB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Deubiquitinase sseL (sseL) CSB-YP838475SXB
CSB-EP838475SXB
CSB-BP838475SXB
CSB-MP838475SXB
CSB-EP838475SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium NAD-dependent dihydropyrimidine dehydrogenase subunit PreT (preT) CSB-YP838476SXB
CSB-EP838476SXB
CSB-BP838476SXB
CSB-MP838476SXB
CSB-EP838476SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Multidrug resistance protein MdtB (mdtB), partial CSB-YP838477SXB
CSB-EP838477SXB
CSB-BP838477SXB
CSB-MP838477SXB
CSB-EP838477SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium D-cysteine desulfhydrase (dcyD) CSB-YP838478SXB
CSB-EP838478SXB
CSB-BP838478SXB
CSB-MP838478SXB
CSB-EP838478SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium UPF0266 membrane protein yobD (yobD), partial CSB-YP838479SXB1
CSB-EP838479SXB1
CSB-BP838479SXB1
CSB-MP838479SXB1
CSB-EP838479SXB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium UPF0263 protein yciU (yciU) CSB-YP838480SXB
CSB-EP838480SXB
CSB-BP838480SXB
CSB-MP838480SXB
CSB-EP838480SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Universal stress protein E (uspE) CSB-YP838481SXB
CSB-EP838481SXB
CSB-BP838481SXB
CSB-MP838481SXB
CSB-EP838481SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>